Lexapro and Rizatriptan benzoate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lexapro (escitalopram oxalate) and Rizatriptan benzoate (rizatriptan benzoate). Common drug interactions include asthenia among females.

The phase IV clinical study analyzes what interactions people have when they take Lexapro and Rizatriptan benzoate. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Lexapro?

Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 91,464 Lexapro users. Check the latest studies of Lexapro.

What is Rizatriptan benzoate?

Rizatriptan benzoate has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 1,886 Rizatriptan benzoate users. Check the latest studies of Rizatriptan benzoate.



On Jul, 27, 2026

21 people who take Lexapro and Rizatriptan benzoate together, and have interactions are studied.

Lexapro and Rizatriptan benzoate drug interactions.

What are the common drug interactions of Lexapro and Rizatriptan Benzoate, by gender? *:

female:

  1. Asthenia (weakness)
  2. Loss of consciousness
  3. Epistaxis (bleed from the nose)
  4. Limb injury
  5. Localised infection (infection at the single location)
  6. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  7. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  8. Fall
  9. Pneumonia
  10. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)

male:

n/a

What are the common drug interactions of Lexapro and Rizatriptan Benzoate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Asthenia (weakness)
  2. Loss of consciousness
  3. Pain in extremity
  4. Tremor (trembling or shaking movements in one or more parts of your body)
  5. Confusional state
  6. Dizziness
  7. Limb injury
  8. Localised infection (infection at the single location)
  9. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  10. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)

30-39:

n/a

40-49:

  1. Breast cancer female
  2. Chest discomfort
  3. Epistaxis (bleed from the nose)
  4. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  5. Rash
  6. Asthma
  7. Dyspnoea (difficult or laboured respiration)
  8. Dyspnoea exertional (breathlessness or shortness of breath)
  9. Heart rate irregular
  10. Infection

50-59:

  1. Fatigue (feeling of tiredness)
  2. Fungal infection
  3. Herpes simplex (herpes simplex is a common viral infection)
  4. Oedema peripheral (superficial swelling)
  5. Pain
  6. Rash
  7. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  8. Urinary tract infection

60+:

  1. Fall
  2. Nausea (feeling of having an urge to vomit)
  3. Asthma
  4. Calculus bladder (bladder stone)
  5. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  6. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  7. Hip fracture
  8. Lymphocyte count decreased
  9. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  10. Nephrolithiasis (calculi in the kidneys)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 23.81%
  2. Headache (pain in head): 5 people, 23.81%
  3. Pain: 4 people, 19.05%
  4. Ankylosing Spondylitis (type of arthritis affecting the spine): 4 people, 19.05%
  5. Acne (skin problems that cause pimples): 4 people, 19.05%
  6. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 14.29%
  7. Muscle Spasms (muscle contraction): 3 people, 14.29%
  8. Asthma: 3 people, 14.29%
  9. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 9.52%
  10. Localised Infection (infection at the single location): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Lexapro and Rizatriptan benzoate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lexapro and Rizatriptan benzoate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lexapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rizatriptan benzoate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lexapro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rizatriptan benzoate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on escitalopram oxalate and rizatriptan benzoate (the active ingredients of Lexapro and Rizatriptan benzoate, respectively), and Lexapro and Rizatriptan benzoate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: